Enhancing Digitally Delivered Diabetes Education With Real-Time CGM
ConditionDiabetes Type 2
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorScripps Whittier Diabetes Institute
About this trial
The current research study will add continuous glucose monitoring devices to the evidence-based text messaging diabetes education program for patients with type 2 diabetes for 6 months. Results on the effectiveness of this intervention will be compared for non-insulin using patients.
Eligibility criteria
Qualifiers
Diagnosed with type 2 diabetes
Are not currently using a CGM
Are not using insulin therapies
Speak English, Spanish or Arabic
Disqualifiers
Are using insulin therapies
Are pregnant
Are currently using a CGM
Are currently participating in another diabetes-related study
Trial design
Treatments tested in this trial
- Dulce Digital Text Messaging Intervention
- CGM Device
Treatment groups
140 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov